News

After 8 months of taking the wrong medication, Miss G developed a rash. Her mother took her to the emergency department (ED) ...
Tividenofusp alfa is a novel central nervous system-penetrant enzyme replacement therapy designed to address the neurological manifestations of MPS II by delivering IDS into the brain and body.
The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.
Products containing synthetic dyes have 141 percent higher mean total sugar, lower levels of sodium, saturated fat.
HealthDay News — There has been nationwide total of 1267 confirmed cases of measles this year, with Kentucky being the latest state to announce an outbreak, the US Centers for Disease Control and ...
National health care expenditure growth expected to outpace GDP, resulting in a health share of GDP that reaches 20.3% by 2033.
Percentage increase in estimated mean annual HTN deaths from excessive alcohol use higher among women than men.
The wearable, transcutaneous neurostimulation device delivers personalized therapy using a proprietary AI algorithm.
The Food and Drug Administration (FDA) has granted accelerated approval to Lynozyfic™ (linvoseltamab-gcpt) for the treatment of adult patients with ...
We spoke with Dr Kellan Baker of the Whitman-Walker institute to shed some light on the many changes taking place to various aspects of medical care for LGBTQ+ individuals.
Gammagard Liquid ERC is a ready-to-use formulation with low IgA content designed to ease administration burden by removing the need to reconstitute.
The Children’s Health Defense sued Meta Platforms, the parent company of Facebook and Instagram. It claimed the company removed their content in violation of free speech rights, NBC News reported.